The development of protective agents against harmful radiations has been a subject of
investigation for decades. However, effective (ideal) radioprotectors and radiomitigators …

Background: Chemoradiotherapy-associated mucositis can manifest as pain, inflammation,
dysphagia, diarrhea, weight loss, rectal bleeding, and infection. Mucositis is a major dose …

Background An increasing number of people survive cancer but a significant proportion
have gastrointestinal side effects as a result of radiotherapy (RT), which impairs their quality …

The intestinal epithelium has high intrinsic turnover rate, and the precise renewal of the
epithelium is dependent on the microenvironment. The intestine is innervated by a dense …

Purpose: Cancer treatment is one of the most challenging diseases in the present era.
Among a few modalities for cancer therapy, radiotherapy plays a pivotal role in more than …

Radiation enteritis (RE) is a common complication in cancer patients receiving radiotherapy.
Although studies have shown the changes of this disease at clinical, pathological and other …

Cancer remains a major cause of death globally. Given its relapsing and fatal features,
curing cancer seems to be something hardly possible for the majority of patients. In view of …

Background Seronegative villous atrophy (SNVA) is commonly attributed to coeliac disease
(CD). However, there are other causes of SNVA. More recently angiotensin-2-receptor …

Abdominal pelvic radiation therapy can induce acute or chronic lesions in the small bowel
wall, called radiation enteritis. Treatment of acute radiation enteritis is essentially …

Importance Systemic therapy and radiotherapy can be associated with acute complications
that may require emergent care. However, there are limited data characterizing …